McKinnell: 2
new Pfizer drugs are 'breakthroughs'
Posted AtTheday.com
Pfizer Inc. Chairman and Chief Executive
Officer Hank McKinnell told an industry forum Wednesday
that two of his company's latest drug candidates could
offer new hope for cancer patients and those suffering
from diabetes.
McKinnell, speaking to a Morgan Stanley conference of
pharmaceutical industry CEOs, said he is bullish about
the prospects for Pfizer's Sutent cancer-fighting drug
as well as Exubera, the world's first inhaled insulin
drug.
January 05, 2006
Full
Story
Elder Pharma up on 'buy' report
Posted AtSify.com
Elder Pharmaceuticals shot up by 4.14
per cent (Rs 10.85) on Wednesday to close at Rs 273
on the BSE. It touched 52-week high of Rs 275 on intra-day.
On the NSE, it touched 52-week high of Rs 275.50.Traders
said a leading brokerage has come out with a `buy' recommendation
on the stock, which resulted in the spike.
January 05, 2006
Full
Story
JB Chemicals enters into agreement
with Taro Pharmaceutical industries
Posted Atmyiris.com
JB Chemicals (Q, N,C,F)* & Pharmaceuticals
Ltd (JBCPL) has entered into a product development agreement
with Taro Pharmaceutical Industries Ltd. (Nasdaq; TARO)
and its affiliates and subsidiaries (`Taro` or the ``company`)
Hawthorne, New York, USA, for the development of several
products jointly for the US market.
January 05, 2006
Full
Story
Pharma companies can benefit
from stem cell research: Expert
Posted AtBusiness
Standard
Contrary to the fear that stem cell research
would affect pharma companies, an international expert
said that it would help them in developing new drugs
to cure complications arising out of the transplantation
process.
January 05, 2006
Full
Story |
